Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Ibrahim, AsmaaJahanifar, Mostafa
Wahab, Noorul
Toss, Michael S
Makhlouf, Shorouk
Atallah, Nehal
Lashen, Ayat G
Katayama, Ayaka
Graham, Simon
Bilal, Mohsin
Bhalerao, Abhir
Ahmed Raza, Shan E
Snead, David
Minhas, Fayyaz
Rajpoot, Nasir
Rakha, Emad
Affiliation
Ibrahim A, Jahanifar M, Wahab N, Toss MS, Makhlouf S, Atallah N, Lashen AG, Katayama A, Graham S, Bilal M, Bhalerao A, Ahmed Raza SE, Snead D, Minhas F, Rajpoot N, Rakha E.Publication date
2023-12-27
Metadata
Show full item recordAbstract
In recent years, artificial intelligence (AI) has demonstrated exceptional performance in mitosis identification and quantification. However, the implementation of AI in clinical practice needs to be evaluated against the existing methods. This study is aimed at assessing the optimal method of using AI-based mitotic figure scoring in breast cancer (BC). We utilized whole slide images from a large cohort of BC with extended follow-up comprising a discovery (n = 1715) and a validation (n = 859) set (Nottingham cohort). The Cancer Genome Atlas of breast invasive carcinoma (TCGA-BRCA) cohort (n = 757) was used as an external test set. Employing automated mitosis detection, the mitotic count was assessed using 3 different methods, the mitotic count per tumor area (MCT; calculated by dividing the number of mitotic figures by the total tumor area), the mitotic index (MI; defined as the average number of mitotic figures per 1000 malignant cells), and the mitotic activity index (MAI; defined as the number of mitotic figures in 3 mm2 area within the mitotic hotspot). These automated metrics were evaluated and compared based on their correlation with the well-established visual scoring method of the Nottingham grading system and Ki67 score, clinicopathologic parameters, and patient outcomes. AI-based mitotic scores derived from the 3 methods (MCT, MI, and MAI) were significantly correlated with the clinicopathologic characteristics and patient survival (P < .001). However, the mitotic counts and the derived cutoffs varied significantly between the 3 methods. Only MAI and MCT were positively correlated with the gold standard visual scoring method used in Nottingham grading system (r = 0.8 and r = 0.7, respectively) and Ki67 scores (r = 0.69 and r = 0.55, respectively), and MAI was the only independent predictor of survival (P < .05) in multivariate Cox regression analysis. For clinical applications, the optimum method of scoring mitosis using AI needs to be considered. MAI can provide reliable and reproducible results and can accurately quantify mitotic figures in BC.Citation
Ibrahim A, Jahanifar M, Wahab N, Toss MS, Makhlouf S, Atallah N, Lashen AG, Katayama A, Graham S, Bilal M, Bhalerao A, Ahmed Raza SE, Snead D, Minhas F, Rajpoot N, Rakha E.Type
ArticleAdditional Links
10.1016/j.modpat.2023.100416PMID
38154653Journal
Modern PathologyPublisher
Mod Patholae974a485f413a2113503eed53cd6c53
10.1016/j.modpat.2023.100416